Changes in expression of bile canalicular CD10 and sinusoidal CD105 (endoglin) in peritumoral hepatic tissue

Tumori

Volumn 95, Issue 4, 2009, Pages 495-500

  Nakamura, Toshitsugu ^a  

^a Suwa Red Cross Hospital   (Japan)

Author keywords

CD10; CD105 (endoglin); Immunohistochemistry; Peritumoral hepatic tissue

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; ENDOGLIN; PARATHYROID HORMONE;

ANTIGEN EXPRESSION; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER METASTASIS; LIVER SINUSOID;

EID: 70350076874     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160909500415     Document Type: Article

References (40)

1. Nakamura T, Hayama M, Sakai T, Hotchi M, Tanaka E: Proliferative activity of hepatocytes in chronic viral hepatitis as revealed by immunohistochemistry for proliferating nuclear cell antigen. Hum Pathol, 24: 750-753, 1993. (Pubitemid 23204653)
2. Farinati F, Cardin R, D'Errico A, De Maria N, Naccarato R, Cecchetto A, Grigioni W: Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Hepatology, 23: 1468-1475, 1996. (Pubitemid 26184401)
3. Kaita KD, Pettigrew N, Minuk GY: Hepatic regeneration in humans with various liver disease as assessed by Ki-67 staining of formalin-fixed paraffin-embedded liver tissue. Liver, 17: 13-16, 1997. (Pubitemid 27092776)
4. 4-induced rat liver injury. Virchows Arch B, 63: 11-16, 1992. (Pubitemid 23007193)
5. Taniguchi E, Sakisaka S, Matsuo K, Tanikawa K, Sata M: Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem, 49: 121-130, 2001. (Pubitemid 32012847)
6. Borscheri N, Roessner A, Rocken C: Canalicular staining of neprilysin (CD10) as a diagnostic marker of hepatocellular carcinoma. Am J Surg Pathol, 25: 1297-1303, 2001. (Pubitemid 32917124)
7. Rocken C, Licht J, Roessner A, Carl-McGrath S: Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma. J Clin Pathol, 58: 1069-1075, 2005. (Pubitemid 41416057)
8. McIntosh GG, Lodge AJ, Watson P, Hall AG, Wood K, Anderson JJ, Angus B, Horne CH, Milton ID: NCL-CD10-270: A new monoclonal antibody recognizing CD10 in paraffin-embedded tissue. Am J Pathol, 154: 77-82, 1999.
9. Shipp MA, Stefano GB, Switzer SN, Griffin JD, Reinherz EL: CD10 (CALLA) neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation. Blood, 78: 1834-1841, 1991.
10. Lebien TW, McCormack RT: The common acute lymphoblastic leukemia antigen (CD10): emancipation from a functional enigma. Blood, 73: 625-635, 1989.
11. Borella L, Sen L, Casper JT: Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-forming and non-E rosette forming ALL blasts. J Immunol, 118: 309-315, 1977. (Pubitemid 8028544)
12. Chu P, Arber DA: Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol, 113: 374-382, 2000. (Pubitemid 30217385)
13. Chu PG, Ishizawa S, Wu E, Weiss LM: Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol, 26: 978-988, 2002. (Pubitemid 34810558)
14. Morrison C, Marsh W Jr, Frankel WL: A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver. Mod Pathol, 15: 1279-1287, 2002.
15. Shousha S, Gadir F, Peston D, Bansi D, Thillainaygam AV, Murray-Lyon IM: CD10 immunostaining of bile canaliculi in liver biopsies: change of staining pattern with the development of cirrhosis. Histopathology, 45: 335-342, 2004. (Pubitemid 39430638)
16. Duff SE, Li C, Garland JM, Kumar S: CD105 is important for angiogenesis: evidence and potential applications. FASEB J, 17: 984-992, 2003. (Pubitemid 36676386)
17. Fonsatti E, Maio M: Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer. J Transl Med, 2: 18, 2004. (Pubitemid 39130354)
18. Ho JW, Poon RT, Sun CK, Xue W-C, Fan S-T: Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver. World J Gastroenterol, 11: 176-181, 2005.
19. Yu J-X, Zhang X-T, Liao Y-Q, Zhang Q-Y, Chen H, Lin M, Kumar S: Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance. World J Gastroenterol, 9: 2866-2869, 2003.
20. Salvesen HB, Gulluoglu MG, Stefansson I, Akslen LA: Significance of CD105 expression for tumor angiogenesis and prognosis in endometrial carcinoma. APMIS, 111: 1011-1018, 2003.
21. Saad RS, Liu YL, Nathan G, Celebrezze J, Medich D, Silverman JF: Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod Pathol, 17: 197-203, 2004.
22. Kyzas PA, Agnantis NJ, Stefanou D: Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma. Virchows Arch, 448: 768-775, 2006. (Pubitemid 43824434)
23. Fonsatti E, Sigalotti L, Arslan P, Altomonte M, Maio M: Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies. Curr Cancer Drug Targets, 3: 427-432, 2003. (Pubitemid 38017479)
24. Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M: Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene, 22: 6557-6563, 2003. (Pubitemid 37372335)
25. Chung YC, Hou YC, Pan AC: Endoglin (CD105) expression in the development of hemorrhoids. Eur J Clin Invest, 34: 107-112, 2004.
26. Tasman F, Dagdeviren A, Kendir B, Er N, Atac A: Endothelial cell and stromal antigens in human periapical granulation tissue. J Endod, 26: 81-84, 2000.
27. Torsney E, Charlton R, Parums D, Collis M, Arthur HM: Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflamm Res, 51: 464-470, 2002. (Pubitemid 35034452)
28. Zhang EG, Smith SK, Charnock-Jones DS: Expression of CD105 (endoglin) in arteriolar endothelial cells of human endometrium throughout the menstrual cycle. Reproduction, 124: 703-711, 2002. (Pubitemid 35407397)
29. Garcia-Monzon C, Sanchez-Madrid F, Garcia-Buey L, Garcia-Arroyo A, Garcia-Sanchez A, Moreno-Otero R: Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology, 108: 231-241, 1995.
30. Asanza CG, Garcia-Monzon C, Clemente G, Salcedo M, Garcia-Buey L, Garcia-Iglesias C, Banares R, Alvarez E, Moreno-Otero R: Immunohistochemical evidence of immunopathogenetic mechanisms in chronic hepatitis C recurrence after liver transplantation. Hepatology, 26: 755-763, 1997. (Pubitemid 27392370)
31. Clemente M, Nunez O, Lorente R, Rincon D, Matilla A, Salcedo M, Catalina MV, Ripoll C, Iacono OL, Banares R, Clemente G, Garcia-Monzon C: Increased intrahepatic and circulating levels of endoglin, a TGF-α co-receptor, in patients with chronic hepatitis C virus infection: relationship to histological and serum markers of hepatic fibrosis. J Viral Hepat, 13: 625-632, 2006.
32. Yu D, Zhuang L, Sun X, Chen J, Yao Y, Meng K, Ding Y: Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma. BMC Cancer, 7: 122, 2007. (Pubitemid 47243913)
33. Shi SR, Cote RJ, Taylor CR: Antigen retrieval techniques: current perspectives. J Histochem Cytochem, 49: 931-937, 2001.
34. Medina J, Sanz-Cameno P, Garcia-Buey L, Martin-Vilchez S, Lopez-Cabrera M, Moreno-Otero R: Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study. J Hepatol, 42: 124-131, 2005. (Pubitemid 40038910)
35. Xu B, Broome U, Uzunel M, Nava S, Kumagai-Braesch M, Hultenby K, Christensson B, Ericzon BG, Holgersson J, Sumitran-Holgersson S: Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis. Am J Pathol, 163: 1275-1289, 2003. (Pubitemid 37175077)
36. Urashima S, Tsutsumi M, Nakase K, Wang JS, Takada A: Studies on capillarization of the hepatic sinusoids in alcoholic liver disease. Alcohol Alcohol Suppl, 1B: 77-84, 1993. (Pubitemid 24082970)
37. Xu GF, Wang XY, Ge GL, Li PT, Jia X, Tian DL, Jiang LD, Yang JX: Dynamic changes of capillarization and peri-sinusoid fibrosis in alcoholic liver diseases. World J Gastroenterol, 10: 238-243, 2004. (Pubitemid 38195270)
38. Gervaz P, Scholl B, Mainguene C, Poitry S, Gillet M, Wexner S: Angiogenesis of liver metastases: role of sinusoidal endothelial cells. Dis Colon Rectum, 43: 980-986, 2000. (Pubitemid 30464071)
39. Li C, Issa R, Kumar P, Hampson IN, Lopez-Novoa JM, Bernabeu C, Kumar S: CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci, 116: 2677-2685, 2003.
40. Corpechot C, Barbu V, Wendum D, Chignard N, Housset C, Poupon R, Rosmorduc O: Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia. A potential mechanism for liver regeneration failure in experimental cirrhosis. Am J Pathol, 160: 613-620, 2002. (Pubitemid 34160339)